Modulation of base hydroxylation by bile acids and salicylates in a model of human colonic mucosal DNA: Putative implications in colonic cancer

Digestive Diseases and Sciences

Volumn 44, Issue 4, 1999, Pages 761-767

  Allgayer, H ^a,b   Kolb, M ^a,b   Stuber, V ^a,b   Kruis, W ^a,b  

^a Oncology Department   (Germany)

^b Augenoptik   (Germany)

Author keywords

5 aminosalicylic acid; Base hydroxylation; Bile acids; Chemoprevention; Colon cancer; Colonic DNA model; Inflammatory bowel disease; N acetyl aminosalicylic acid; Salicylate

Indexed keywords

BILE ACID; MESALAZINE; SALICYLIC ACID DERIVATIVE;

ARTICLE; COLON CANCER; COLON MUCOSA; CONCENTRATION RESPONSE; DNA CONTENT; DNA DAMAGE; DNA MODIFICATION; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; HYDROXYLATION; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL;

EID: 0032945146     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026670027150     Document Type: Article

References (39)

1. 1. Bruce WR: Recent hypothesis for the origin of colon cancer. Cancer Res 47:4237-4242, 1987
2. 2. Bayerdörffer E, Mannes GA, Richter O, Ochsenkühn T, Wiebecke B, Koepke W, Paumgartner G: Increased serum deoxycholate acid levels in men with colorectal adenomas. Gastroenterology 104:145-151, 1993
3. 3. Stadler J, Yeung KS, Furrer R, Marcon N, Himal HS, Bruce WR: Proliferation activity of rectal mucosa and soluble fecal bile acids in patients with normal colon and in patients with colonic polyps or cancer. Cancer Lett 38:315-320, 1988
4. 4. Thun MJ: NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin North Am 25:333-348, 1996
5. 5. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO: Risk factors for colorectal cancer in patients with ulcerative colitis: A case control study. Gastroenterology 107:117-120, 1994
6. 6. Bachwich DR, Lichtenstein GR, Traber PG: Cancer in inflammatory bowel disease. Med Clin North Am 78:1399-1412, 1994
7. 7. Ekbom A, Kornfeld K: Sulphasalazine use as a preventive factor for colorectal cancer in ulcerative colitis patients a review. Inflamm Bowel Dis 2:276-278, 1996
8. 8. Lutz WK: Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis. Mutat Res 238:287-295, 1990
9. 9. Sargentini NJ, Smith KC: Spontaneous mutagenesis: The roles of DNA repair, replication and recombination. Mutat Res 254:1-27, 1985
10. 10. Ames BN, Gold LS: Chemical carcinogencsis: Too many rodent carcinogens. Proc Natl Acad Sci USA 87:7772-7776, 1990
11. 11. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA: 8-Hydroxyguanine, an abundant form of oxidative DNA damage causes G → T and A → C substitutions. J Biol Chem 267:166-172, 1992
12. 12. Shigenaga MK, Gimeno CJ, Ames BN: Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 86:9697-9701, 1986
13. 13. Arouma OK, Halliwell B, Gajewski E, Dizdaroglu M: Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J Biol Chem 264:20509-20512, 1989
14. 14. Malins DC, Haimanot R: Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 51:5430-5432, 1991
15. 15. Malins DC, Polissar NL, Nishikada K, Holmes EH, Gardener HS, Gunselmann SJ: The etiology and prediction of breast cancer. Cancer 75:503-517, 1995
16. 16. DeMaria N, Colantoni A, Maidt L, Rogers B, Faginoli S, Farinati F, Van Thiel DH, Floyd RA: Increased DNA and RNA oxidative damage in tumoral tissue from subjects with hepatocellular carcinoma and chronic viral hepatitis. Gastroenterology 106:A1179, 1996
17. 17. Harada N, Takabayashi F, Kaneko T, Tahara S: Effect of green tea catechins on the amount of 8-hydroxydeoxyguanosine in pancreatic and hepatic nuclear DNA after N-nitrosobis (2-oxopropyl) amine administration. European Pancreatic Club and the International Association of Pancreatology, Mannheim 1996, abstract 16
18. 18. Farinati F, Cardin R, Rugge M, Di Mario F, Bonvicini P, Naccarato R: Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 42:351-356, 1998
19. 19. Allgayer H, Kruis W, Paumgartner G: Studies on the in vitro binding of penicillamine to cholestyramine. Experientia 38:482-484, 1982
20. 20. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerehia R, Kahn E, Weissman G, Katz S, Floyd R, McKinley MJ, Fisher SE, Mullin GE: Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41:2078-2086, 1996
21. 21. DNA/RNA Isolation Kit: United States Biochemical Corporation, Cleveland, Ohio
22. 22. Dizdaroglu M: Chemistry of free radical damage to DNA and nucleoproteins. In DNA and Free Radicals. B Halliwell, OI Arouma (eds). New York, Ellis Horwood, 1993, pp 19-39
23. 23. Dizdaroglu M: Application of capillary chromatography-mass spectrometry to chemical characterization of radiation-induced base damage of DNA: Implications for assessing DNA repair processes. Anal Biochem 144:593-603, 1985
24. 24. Allgayer H, Höfer P, Schmidt M, Böhne P, Kruis W, Gugler R: Superoxide, hydroxyl and fatty acid radical scavenging by aminosalicylates. Biochem Pharmacol 43:259-263, 1992
25. 25. Allgayer H, Such P, Klotz U, Fischer C, Kruis W: Formation and inhibition of deoxyribose radicals: Potential disease mechanisms and modes of action of aminosalicylates in inflammatory bowel disease. Magn Reson Med 6:239-241, 1995
26. 26. Schoppmeyer K, Keim V, Mössner J: The tumor suppressor gene p53 - function and significance. Z Gastroenterol 35:491-504, 1997
27. 27. Schmutte C, Yang AS, Beart RW, Jones PA: Base excision repair of U:G mismatches at a mutational hotspot in the p53 gene is more efficient than base excision repair of T:G mismatches in extracts of human colon tumors. Cancer Res 55:3742-3746, 1995
28. 28. Grisham MB: Oxidants and free radicals in inflammatory bowel disease. Lancet 334:859-861, 1994
29. 29. Brasitus TA: Primary chemoprevention strategies for colorectal cancer: Ursodeoxycholic acid and other agents. Gastroenterology 109:2036-2038, 1995
30. 30. Rigas B, Tsoulias GJ, Allan C, Wali RK, Brasitus TA: The effects of bile acid and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development. Immunology 83:319-323, 1994
31. 31. Cheah PY, Bernstein H: Colon cancer and dietary fiber: Cellulose inhibits the DNA damaging ability of bile acids. Nutr Cancer 13:51-57, 1990
32. 32. Krag E, Phillips SF: Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. J Clin Invest 53:1686-1694, 1974
33. 33. Fischer-Nielsen A, Poulsen HE, Loft S: 8-Hydroxydeoxyguanosine in vitro: Effects of glutathione, ascorbate and 5-aminosalicylic acid. Free Radic Biol Med 13:121-126, 1992
34. 34. Jackson JH, Gajewski E, Schraufstatter I, Hyslop PA, Fuciarelli AF, Cochrane CG, Dizdaroglu M: Damage to the bases in DNA induced by stimulated human neutrophils. J Clin Invest 84:1644-1649, 1989
35. 35. Cravo M, Albuquerque C, Salazar de Sousa L, et al.: Microsatellite instability in nonneoplastic mucosa from patients with long-standing ulcerative colitis: Correlations with folate status. Gastroenterology 112:A552, 1997
36. 36. Lauritsen K, Hansen J, Ryde M, Rask-Madsen J: Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis. Gastroenterology 86:1496-1500, 1984
37. 37. Rainford KD: The effects of aspirin and other non-steroid antiinflammatory analgesic drugs on gastrointestinal mucus glycoprotein biosynthesis in vivo: Relationship to ulcerogenic actions. Biochem Pharmacol 27:877-885, 1978
38. 38. Harris RM, Hawker RJ, Langman MJS, Singh S, Waring RH: Inhibition of phenolsulphotransferase by salicylaic acid: A possible mechanism by which aspirin may reduce carcinogenesis. Gut 42:272-275, 1998
39. 39. Gustafson-Svard C, Hallböök O, Sjödahl R: Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinoma and in azoxymethane induced colonic tumors in rats. Gut 38:79-84, 1996